Loading clinical trials...
Loading clinical trials...
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia: A Blinded Randomized Sham-Controlled Trial
Conditions
Interventions
Focused Ultrasound
Locations
4
United States
University of Minnesota Medical Center Fairview
Minneapolis, Minnesota, United States
Northwell Health - The Feinstein Institutes of Clinical Research
Manhasset, New York, United States
University of Utah
Salt Lake City, Utah, United States
WVU Rockefeller Neuroscience Institute
Morgantown, West Virginia, United States
Start Date
December 11, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
April 16, 2026
NCT07358754
NCT05901259
NCT03759522
NCT07398417
NCT07230171
NCT04806620
Lead Sponsor
SPIRE Therapeutics Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions